Thought Leaders Listed in Alphabetical Order December 2005 Year in Preview 2006 Meredith Abreu. VP of Research, Manhattan Research LLC, New York; Manhattan Research is a provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch.com. A.N. Aditya. Research Analyst, Frost & Sullivan, New York; Frost & Sullivan is a global growth consulting company that has been partnering with clients to support the development of innovative strategies for more than 40 years. For more information, visit frost.com. Murray Aitken. Senior VP, Corporate Strategy, IMS Health, Fairfield, Conn.; IMS Health is a leading provider of information solutions to the pharmaceutical and healthcare industries. For more information, visit imshealth.com. Paul W. Allen. Managing Partner, Life Sciences Practice, Clarkston Consulting, Durham, N.C.; Clarkston Consulting is a global management and technology consulting firm that provides strategic business solutions for clients within the life-sciences and consumer products industries worldwide. For more information, visit clarkstonconsulting.com. Rick Angello. Senior VP, General Manager, i3 DLN, Basking Ridge, N.J.; i3 DLN, a business unit of i3, is a full-service, accredited provider of certified medical education. For more information, visit i3dln.com. Jack Armstrong. CEO, The Genaera Corp., Plymouth Meeting, Pa.; Genaera is a biopharmaceutical company committed to developing medicines to address substantial unmet medical needs in major pharmaceutical markets, including treatments of eye, cancer, and respiratory disorders. For more information, visit genaera.com. Barry Arnold, M.B., B.Ch. VP, Clinical Drug Safety, AstraZeneca, Alderly Park, United Kingdom; AstraZeneca is a leading, global pharmaceutical company. For more information, visit astrazeneca.com. Cecilia Arradaza. Chandler Chicco Agency, Washington, D.C.; Chandler Chicco, with headquarters in New York, is a full-service healthcare public-relations firm specializing in global and country-specific corporate campaigns. For more information, visit ccapr.com. Rudy Bakalov, CISSP. Senior Manager, Ernst & Young LLP, Security and Technology Solutions, New York; Ernst & Young helps organizations form the right alliances, access funding, and gain insight into the market and regulatory environment of today’s dynamic health-sciences market. For more information, visit ey.com. Jill Balderson. VP, Strategic Marketing Services, HealthEd, Clark, N.J.; HealthEd develops patient-education programs for pharmaceutical and healthcare marketers. For more information, visit healthed.com. Mark Bard. President, Manhattan Research LLC, New York; Manhattan Research is provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch.com. Ellen Barrosse. CEO, Synchrogenix Information Strategies Inc., Wilmington, Del.; Synchrogenix delivers science and marketing communication strategies and services to business sectors from pharmaceuticals and agriculture to energy and banking in U.S. and global markets. For more information, visit synchrogenix.com. Charles Blenner, R.Ph., M.P.A. Senior Project Manager, Interactive Voice Response Services, Covance Inc., Princeton, N.J.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. Eric Bolesh. Research Team Leader, Cutting Edge Information, Research Triangle Park, N.C.; Cutting Edge Information provides innovative, implementable research and consulting to the pharmaceutical and the financial services industries. For more information, visit cuttingedgeinfo.com. Brian Bollwage. Executive Director, Regulatory Affairs, i3 Research, Basking Ridge, N.J.; i3 Research, a business unit of i3, is a full-service, global CRO specializing in oncology, central nervous system, and respiratory and infectious diseases. For more information, visit i3research.com. Jeff Brady. President of Advanced Health Media, Union, N.J.; Advanced Health Media provides a fully integrated suite of hosted technology solutions and sales-support services designed to address the diverse operational and compliance management needs of clients. For more information, visit ahmdirect.com. Melanie A. Bruno, Ph.D., MBA. VP, Regulatory Affairs and Quality, Kendle, Cincinnati; Kendle is among the world’s leading global clinical research organizations, delivering innovative and robust clinical development solutions to biopharmaceutical companies. For more information, visit kendle.com. Charles Buckwell. Chief Executive, Complete Medical Group, Cheshire, United Kingdom, and New York; CMG, including Complete Medical Communications, is a global medical communications agency and a division of Torre Lazur McCann Healthcare Worldwide. For more information, visit complete-grp.com. G. Steven Burrill. CEO, Burrill & Company, San Francisco; Burrill is a global leader in life sciences whose principal activities are in venture capital, merchant banking, and media. For more information, visit burrillandco.com. Joe Carofano. CCA Advertising, New York; CCA Advertising is a full-service advertising company specializing in healthcare communications. For more information, visit ccaad.com. Daniel B. Carr, M.D. CEO and Chief Medical Officer, Javelin Pharmaceuticals Inc., New York; Javelin is a specialty pharmaceutical company committed to the development of drugs to treat intense, moderate-to-severe pain. For more information, visit javelinpharmaceuticals.com. Jay Carter. Senior VP, Director of Client Services, Abelson-Taylor Inc., Chicago, Abelson-Taylor is a full-service healthcare advertising agency. For more information, visit abelson-taylor.com. Arnold Chan, M.D., Sc.D. Senior Scientist, i3 Drug Safety, Basking Ridge, N.J.; i3 Drug Safety, a business unit of i3, provides epidemiology and drug-safety services. For more information, visit i3global.com. Mani Chidambaram. Director, Learning and Development, Esprit Pharma Inc., East Brunswick, N.J.; Esprit Pharma is a niche-oriented, forward-thinking pharmaceutical company committed to improving patient outcomes and well-being within the genito-urinary and women’s healthcare fields. For more information, visit espritpharma.com. Mark Christmyer. Managing Director, inRx Medical Education, Philadelphia; inRx, a wholly owned independent medical-education subsidiary of Dorland Global Corp., provides a broad range of clinical, educational, continuing medical education, and third-party initiatives. For more information, visit inrx.com. William Claypool, M.D. CEO and Chairman, Phoenix Data Systems Inc., King of Prussia, Pa.; Phoenix Data Systems delivers cost-effective EDC and data management services. For more information, visit phoenixdatasystems.net. Shabbir Dahod. CEO, SupplyScape Corp., Cambridge, Mass.; SupplyScape provides electronic pedigree software and expertise to safeguard and secure the pharmaceutical supply chain. For more information, visit supplyscape.com. Charles R. DeLoach. VP, Sales, Nabi Biopharmaceuticals, Boca Raton, Fla.; Nabi leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. For more information, visit nabi.com. Glen de Vries. Chief Technology Officer, Medidata Solutions Worldwide, New York; Medidata Solutions offers flexible, enterprise-class workflow and Web-based technology that assists global life-sciences and research organizations to accelerate the process of bringing life-enhancing treatments to market. For more information, visit medidatasolutions.com. Sean Dougherty. Senior Director, Medicare Strategy and Patient Assistance Programs, AstraZeneca, Wilmington, Del.; AstraZeneca is a leading, global pharmaceutical company. For more information, visit astrazeneca.com. Claire Driscoll. Founder and President, Claire Driscoll & Associates Inc., Saint John, New Brunswick, Canada; Claire Driscoll is a call center providing a wide range of marketing services to the clinical-research industry by integrating data collection and patient recruitment. For more information, visit clairedriscollassociates.com. David S. Duplay. Senior VP, Marketing, MedManage Systems Inc., Bothell, Wash.; MedManage provides prescription drug sampling solutions. For more information, visit medmanagesystems.com. Cameron Durrant, M.D., MBA. President and CEO, PediaMed – The Pediatrics Company, Florence, Ky.; PediaMed specializes in the health and well-being of children. For more information, visit pediamedpharma.com. Hakan S. Edstrom. President, Chief Operating Officer, and Director, MannKind Corp., Valencia, Calif.; MannKind is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. For more information, visit mannkindcorp.com. Frank Eeckman, M.D., Ph.D. Editor, The Centient Biotech Investor, published by Centient Consulting Inc., San Diego; Centient is a newsletter and Website providing professional investors and investment advisors with analysis on public and private biotechnology companies. For more information, visit biotechinvestor.com. Mario Ehlers, M.D., Ph.D. Chief Medical Officer, Pacific Biometrics Inc., Seattle; PBI is a dedicated applied-research facility providing comprehensive central laboratory services for clinical research in support of pharmaceutical, biotech, and laboratory diagnostic manufacturers. For more information, visit pacbio.com. Monica English. Project Manager, Interactive Voice Response Services, Covance Inc., Princeton, N.J.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. Elio Evangelista. Senior Analyst, Cutting Edge Information, Research Triangle Park, N.C.; Cutting Edge Information provides innovative, implementable research and consulting to the pharmaceutical and the financial services industries. For more information, visit cuttingedgeinfo.com. David A. Evans. Chief Information Officer, Octagon Research Solutions Inc., Wayne, Pa.; Octagon Research Solutions offers a comprehensive suite of regulatory, clinical, process, and information-technology solutions to the life-sciences industry. For more information, visit octagonresearch.com. James Featherstone. Global Head of Consulting, Wood Mackenzie, Boston; Wood Mackenzie provides a range of consulting services and research products to the life-sciences and energy industries. For more information, visit woodmac.com. Shelli Field. President, TVG Marketing Research & Consulting, Dresher, Pa.; TVG is a global brand knowledge, marketing, consulting, and training company dedicated to providing strategic insights that drive brand growth. For more information, visit tvg-inc.com. Heather Fraser. Global Life Sciences/Pharma Lead, IBM Institute for Business Value, White Plains, N.Y.; The IBM Institute for Business Value provides senior executives with strategic insights and recommendations that address critical business challenges and capitalize on new opportunities, all with an eye on creating value. For more information, visit ibm.com/iibv. Scott Freedman. President, Monitorforhire.com, Conshohocken, Pa.; Monitorforhire.com is a Web-enabled resource management company providing qualified, regional independent clinical monitors to the pharmaceutical, biotechnology, medical-device, and contract research industries. For more information, visit monitorforhire.com. Paul E. Freiman. President and CEO, Neurobiological Technologies Inc., Emeryville, Calif.; Neurobiological Technologies is a drug-development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. For more information, visit ntii.com. Steve Gallopo. Director, Marketing, New Product Planning, Stiefel Laboratories Inc., Duluth, Ga.; Stiefel Laboratories is a specialized pharmaceutical company that focuses on the advancement of dermatology and skin care around the world. For more information, visit stiefel.com. Tim R. Garde. Executive VP and General Manager, Vox Medica, Philadelphia; Vox Medica is an independent healthcare communications company. For more information, visit voxmedica.com. Philip George. Managing Partner, Health & Life Sciences Practice, Accenture, New York; Accenture is a global management consulting, technology services, and outsourcing company. For more information, visit accenture.com. Mark D. Gessler. CEO and President, Gene Logic Inc., Gaithersburg, Md.; Gene Logic is leading the transformation of pharmaceutical research and development with its extensive gene expression databases, pioneering efforts in toxicogenomics, sophisticated bioinformatics expertise, specialty nonclinical testing capabilities, and cutting-edge technology programs for drug repositioning. For more information, visit genelogic.com. Matt Giegerich. President and CEO, CommonHealth, Parsippany, N.J.; CommonHealth is a leading healthcare communications resource and a WPP Group company. For more information, visit commonhealth.com. Mark A. Goldberg, M.D. President, Clinical Research Services and Perceptive Informatics, Parexel International, Waltham, Mass.; Parexel is a global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical marketing, consulting services, and technology products and services to the worldwide pharmaceutical, biotechnology, and medical-device industries. For more information, visit parexel.com. Mark Goldstone. CEO, Interbrand Wood, New York; Interbrand Wood is a full-service brand consultancy, dedicated to the healthcare industry that partners with pharmaceutical, biotech, medical-device, and animal-health companies to develop and manage some of their most valuable assets — their brands. For more information, visit interbrandwood.com. Marita Gomez. Partner, HealthInfo Direct LLC, Schaumburg, Ill.; HealthInfo Direct is a marketing/communications agency that specializes in public relations and direct marketing. For more information, visit healthinfodirect.com. Anne Goodrich. Director of Research, The Pri-Med Institute, Boston; Pri-Med is the clinical-education division of M|C Communications LLC and is structured to provide credited continuing education programs. For more information, visit pri-medinstitute.org. Thomas Goss. VP, Covance Market Access Services, Covance Inc., Gaithersburg, Md.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. Daniel E. Greenleaf. President and CEO, VioQuest Pharmaceuticals Inc., Monmouth Junction, N.J.; VioQuest Pharmaceuticals’ strategy is to acquire, develop, and commercialize targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, and viral and autoimmune disorders. For more information, visit vioquestpharm.com. Richard Greif. Project Director, Opinion Dynamics Corp., Cambridge, Mass.; Opinion Dynamics is a market research and consulting company. For more information, visit opiniondynamics.com. Cort Grey. Director, Sales and Marketing, Dendrite Clinical, Bedminster, N.J.; Dendrite Clinical, a division of Dendrite International, offers a set of solutions to benefit conductors of clinical trials in effectively initiating studies, identifying potential investigators and patients, providing ongoing training and support to trial sites, conducting pre- and post-marketing risk assessments, facilitating safety reporting, and providing data analysis of trial and competitive drugs. For more information, visit dendrite.com. Jon Hess. Project Team Leader, Cutting Edge Information, Research Triangle Park, N.C.; Cutting Edge Information provides innovative, implementable research and consulting to the pharmaceutical and the financial services industries. For more information, visit cuttingedgeinfo.com. Simon S. Higginbotham. VP and Chief Marketing Officer, Kendle, Cincinnati; Kendle is among the world’s leading global clinical research organizations, delivering innovative and robust clinical-development solutions to biopharmaceutical companies. For more information, visit kendle.com. Travis Hollingsworth. Senior Manager, Life Sciences Solutions, Clarkston Consulting, Durham, N.C.; Clarkston Consulting is a global management and technology consulting firm that provides strategic business solutions for clients within the life-sciences and consumer products industries worldwide. For more information, visit clarkstonconsulting.com. Marysasser Holloway. Director, Data and Analytical Services, ClinForce, Research Triangle Park, N.C.; ClinForce delivers outsourcing and staffing solutions to companies in the pharmaceutical, biotechnology, and device industries. For more information, visit clinforce.com. Chris Holt. VP, UPS Supply Chain Solutions, Alpharetta, Ga.; UPS synchronizes the flow of goods, funds, and information for business. For more information, visit ups-scs.com. Patrick Hughes. Director, Marketing and Strategic Business Development, ClinPhone Group Ltd., Nottingham, United Kingdom; ClinPhone is a global provider of clinical-trial technology solutions. For more information, visit clinphone.com. R. Douglas Hulse. President and Chief Operating Officer, Hemispherx Biopharma Inc., Philadelphia; Hemispherx is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for the treatment of chronic viral and immune-based disorders. For more information, visit hemispherx.net. Ellen Julian. Research Director, Pharmaceutical Outsourcing Markets, Life Science Insights (LSI), Framingham, Mass.; LSI, an IDC Company, provides market research, analysis, and consulting services to decision makers in life-sciences markets. For more information, visit lifescience-insights.com. Kenneth I. Kaitin. Director, Tufts Center for the Study of Drug Development, Boston; Tufts CSDD provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and use. For more information, visit csdd.tufts.edu. Holly Knighton, CPHIT, CPEHR. Healthcare Payer Sales Executive, Worldwide, IBM Healthcare & Life Sciences Industry, White Plains, N.Y.; IBM provides senior executives with strategic insights and recommendations that address critical business challenges and capitalize on new opportunities, all with an eye on creating value. For more information, visit ibm.com. Ron Koprowski. Head Sales Training Practice, The Forum Corp., Boston; The Forum Corp. is a global organizational learning consultant serving medium- and large-sized companies. For more information,visit forum.com. Mary LaFleur. Creative Director, DVC HealthCare, Yardley, Pa.; DVC HealthCare fuses scientific expertise with strategic and creative marketing solutions to improve brand speed to market, accelerate brand uptake, and increase brand loyalty for clients in North America and Europe. For more information, visit dvchealthcare.com. eric langer. President and Managing Partner, BioPlan Associates Inc., Rockville, Md.; BioPlan Associates provides market assessment and research to biopharmaceutical, biotechnology, and healthcare companies. For more information, visit bioplanassociates.com. Pierre Laurin. Chairman, President, and CEO, ProMetic Life Sciences Inc., Montreal, Canada; ProMetic is a biopharmaceutical company specializing in the research, development, manufacture, and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand enabling technology. For more information, visit prometic.com. Jay Levy. President, Adair-Greene Healthcare Communications, Atlanta; Adair-Greene offers a full range of services geared toward successful product introduction or the creation and maintenance of a competitive advantage for products already on the market. For more information, visit aghealthcare.com. Warren Levy. Chief Strategy Officer and Senior VP, Vox Medica, Philadelphia; Vox Medica is an independent healthcare communications company. For more information, visit voxmedica.com. Anne M. Loomis. Executive VP, Torre Lazur McCann West, San Diego; Torre Lazur McCann West is part of Torre Lazur McCann Healthcare Worldwide, a global full-service healthcare communications agency. For more information, visit torrelazur.com. Alan Lotvin, M.D. President and Chief Operating Officer, M|C Communications LLC, Boston; M|C Communications is a provider of continuing education for physicians and other healthcare professionals and produces the Pri-Med network of more than 140 medical conferences in 70 cities across the country. For more information, visit mc-comm.com. Alan Louie. Research Director, Life Science Insights (LSI), Framingham, Mass.; LSI, an IDC Company, provides market research, analysis, and consulting services to decision makers in life-sciences markets. For more information, visit lifescience-insights.com. Mike Luby. CEO, TargetRx Inc., Horsham, Pa.; TargetRx is a pharmaceutical marketing information services company that delivers actionable insights to improve brand performance. For more information, visit targetrx.com. Carolyn Buck Luce. Leader, Metro New York Pharmaceutical Sector, Ernst & Young LLP, New York; Ernst & Young helps organizations form the right alliances, access funding, and gain insight into the market and regulatory environment of today’s dynamic health-sciences market. For more information, visit ey.com. Terri Madison, Ph.D., MPH. President, i3 Drug Safety, Basking Ridge, N.J.; i3 Drug Safety, a business unit of i3, provides epidemiology and drug safety services. For more information, visit i3global.com. Maureen Mangiavas. Senior Director, Business Development, The Hal Lewis Group Inc., Philadelphia; Hal Lewis is a full-service healthcare communications and advertising agency. For more information, hlg.com. Elizabeth Mann, Ph.d. Director, Medical Affairs, Esprit Pharma Inc., East Brunswick, N.J.; Esprit Pharma is a niche-oriented, forward-thinking pharmaceutical company committed to improving patient outcomes and well-being within the genito-urinary and women’s healthcare fields. For more information, visit espritpharma.com. Jay W. Mason, M.D. Medical Director, Chair, Cardiovascular Sciences Group, Covance Cardiac Safety Services, Reno, Nev.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. Chris Mattingly. Director, Life Sciences, Clarkston Consulting, Durham, N.C.; Clarkston Consulting is a global management and technology consulting firm that provides strategic business solutions for clients within the life-sciences and consumer products industries worldwide. For more information, visit clarkstonconsulting.com. John McDermott. VP, Covance Market Access Services, Covance Inc., Gaithersburg, Md.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. David McGirr, MBA. Senior VP, Chief Financial Officer, Cubist Pharmaceuticals Inc., Lexington, Mass.; Cubist is a biopharmaceutical company focused on the research, development, and commercialization of products that address unmet medical needs in the acute-care environment. For more information, visit cubist.com. Kevin McNelly. VP, Supply Chain Operations, MedImmune Inc., Gaithersburg, Md.; MedImmune is dedicated to advancing science and medicine to help people live better lives; the company is focused on the areas of infectious diseases, cancer, and inflammatory diseases For more information, visit medimmune.com. Lawrence A. Meinert, M.D., MPH. VP, Medical and Scientific Affairs, Late Stage Development Services, Covance Inc., Princeton, N.J.; Covance is one of the world’s largest and most comprehensive drug-development services companies. For more information, visit covance.com. Geoff Melick. VP, Managing Director, Kinect, Chicago; Kinect, a business unit of Corbett Accel Healthcare Group, provides a full range of digital marketing services that assist clients to build strong relationships with customers through dynamic communications. For more information, visit kinect.com. Donna L. Mendrick, Ph.D. Scientific Fellow and VP, Toxicogenomics, Gene Logic Inc., Gaithersburg, Md.; Gene Logic is leading the transformation of pharmaceutical research and development with its extensive gene expression databases, pioneering efforts in toxicogenomics, sophisticated bioinformatics expertise, specialty nonclinical testing capabilities, and cutting-edge technology program for drug repositioning. For more information, visit genelogic.com. Marsha Meyer, R.Ph. Senior VP, Clinical Information, CME LLC, Irvine, Calif.; CME provider of fully accredited continuing medical education programs and offers a wide range of informational and educational resources for healthcare professionals. For more information, visit cmellc.com. Ellen G. Miller. Biosector 2, New York; Biosector 2 drives communications for clients that are leading scientific discovery and development and who need support in reaching key stakeholders. For more information, visit biosector2.com. Steve Miller, M.D. VP, Research, Express Scripts Inc., St. Louis; Express Scripts is one of the largest pharmacy benefit management (PBM) companies in North America, providing PBM services to more than 55 million patients through facilities in 13 states and Canada. For more information, visit express-scripts.com. Michael G. Minor. VP, Late Phase Services, ICON Clinical Research, New York; ICON Clinical Research is a full-service clinical research organization providing a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology, and device industries. For more information, visit iconclinical.com. William Moffitt. President and CEO, Nanosphere Inc., Northbrook, Ill.; Nanosphere’s mission is to create new standards in discovery, medical care, and public safety through the application of proprietary nanotechnology. For more information, visit nanosphere-inc.com. Celeste Mosby. VP of Industry Marketing, Pharmaceutical, Biotech & Medical Devices, Wilson Learning Worldwide, Edina, Minn.; Wilson Learning is a global leader in human performance improvement solutions for Fortune 500 and emerging organizations, with operations in the United States and 30 other countries worldwide. For more information, visit wilsonlearning.com. Michael Murphy, M.Sc. President and CEO, Gentris Corp., Morrisville, N.C.; Gentris is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions. For more information, visit gentris.com. Tim Noffke. VP, Life Sciences, Integrated Project Management Co. Inc., Burr Ridge, Ill.; IPM provides project-management leadership to the life-sciences and other industries. For more information, visit ipmcinc.com. Sean Nolan. VP, Sales and CNS Marketing, Ovation Pharmaceuticals, Deerfield, Ill.; Ovation is a fully intergrated, global pharmaceutical company that acquires, develops, manufactures, and markets branded prescription products that satisfy unmet medical needs in severely ill patient populations. For more information, visit ovationpharma.com. Paul Nowak. Executive VP and Chief Operating Officer, Symyx Technologies Inc.; Santa Clara, Calif.; Symyx is dedicated to helping customers maximize the effectiveness and success of their research and development programs. For more information, visit symyx.com. Mark Perlotto. Executive VP, Chief Marketing Officer, Adair-Greene Healthcare Communications, Atlanta; Adair-Greene offers a full range of services geared toward successful product introduction or the creation and maintenance of a competitive advantage for products already on the market. For more information, visit aghealthcare.com. Donald J. M. Phillips, Pharm.D. Principal and CEO, Vox Medica, Philadelphia; Vox Medica is an independent healthcare communications company. For more information, visit voxmedica.com. Bernard Poussot. President, Wyeth Pharmaceuticals, Madison, N.J.; Wyeth is one of the world’s largest research-driven pharmaceutical and healthcare products companies and a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and nonprescription medicines that improve the quality of life for people worldwide. For more information, visit wyeth.com. Charlene Prounis. Copresident, Flashpoint Medica, New York; Flashpoint Medica’s lead strategy is to help brand managers identify — and ignite — these critical moments for change. For more information, visit flashpointmedica.com. Charanya Ramachandran. Healthcare Analyst, Frost & Sullivan, New York; Frost & Sullivan publishes market consulting information and intelligence on emerging high-technology and industrial markets. For more information, healthcare.frost.com. Dr. Keith Redpath. Head Life Sciences Research, Wood Mackenzie, Boston; Wood Mackenzie provides a range of consulting services and research products to the life-sciences and energy industries. For more information, visit woodmac.com. Amanda C. Rhodes, MPH, CHES. VP, Behavioral Solutions, MicroMass Communications Inc., Cary, N.C.; MicroMass Communications is a full-service relationship marketing agency that brings behavioral science to the design, implementation, and measurement of acquisition and loyalty programs. For more information, visit micromass.com. John Rhodes. U.S. & Global Managing Partner, Life Sciences, Life Sciences & Health Care Practice, Deloitte & Touche USA LLP, New York; Deloitte delivers services in four professional areas — audit, tax, consulting, and financial advisory services. For more information, visit deloitte.com. John Riabov. President, Windwood Consulting LLC, Landenberg, Pa.; Windwood uses quality improvement tools, including Six Sigma Methodology, to increase customer satisfaction and improve the bottom line. For more information, visit windwoodconsulting.com. Nick Richards. Chief Operating Officer, DataLabs Inc., Irvine, Calif.; DataLabs is an innovative developer of Internet-based applications for clinical development that help the biopharmaceutical industry accelerate clinical trials with proven software for study design, data capture, and data management. For more information, visit datalabs.com. John Rothman, M.D. VP, Clinical Development, Advaxis, Princeton, N.J.; Advaxis is a biotechnology company that uses live, genetically modified Listeria monocytogenes to treat cancers, infectious disease, and problems of the immune system. For more information, visit advaxis.com. John Ryder. VP, Skyscape Inc., Marlborough, Mass.; Skyscape is a provider of trusted medical references formatted especially for mobile and handheld devices. For more information, visit skyscape.com. Lora Schwab, Ph.D. President, i3 Statprobe, Basking Ridge, N.J.; i3 Statprobe, a business unit of i3, provides data and biostatistical services to the pharmaceutical and biotechnology industries across all phases of research. For more information, visit i3statprobe.com. Greg Scott. Founder and Principal Analyst, Centient Consulting Inc., publishers of The Centient Biotech Investor, San Diego, and President and Cofounder of Life Science Angels Inc., San Diego; Centient is a newsletter and Website providing professional investors and investment advisors with analysis on public and private biotechnology companies, Life Science Angels is an angel investment group focusing on early-stage biotechnology and medical-device companies. For more information, visit biotechinvestor.com. Marissa Seligman. Chief Clinical and Regulatory Affairs Officer, The Pri-Med Institute, Boston; Pri-Med is the clinical education division of M|C Communications LLC and is structured to provide credited continuing education programs. For more information, visit pri-medinstitute.org. Bruce Seligmann, Ph.D. Founder, Chairman, and Chief Scientific Officer, High Throughput Genomics Inc., Tucson, Ariz.; High Throughput Genomics’ mission is to create custom discovery tools so that pharmaceutical researchers can bring better drugs to patients faster. For more information, visit htgenomics.com. Mollie Shields-Uehling. President and CEO, SAFE-BioPharma Association, New York; SAFE-BioPharma is a network of recognized trusted biopharmaceutical and healthcare professionals created to support the management and maintenance of an identity assurance standard called secure access for everyone (SAFE) with the mission to reduce the complexity and cost of managing paper for the global healthcare community by delivering unique electronic identity credentials for legally enforceable and regulatory compliant digital signatures. For more information, visit safe-biopharma.org. Brajinder Singh. Director, Supply Chain Solutions, Clarkston Consulting, Durham, N.C.; Clarkston Consulting is a global management and technology consulting firm that provides strategic business solutions for clients within the life-sciences and consumer products industries worldwide. For more information, visit clarkstonconsulting.com. Todd Skrinar. Partner, Healthcare and Life Sciences, Unisys, Blue Bell, Pa.; Unisys is a worldwide technology services and solutions company. For more information, visit unisys.com. Chris Smith. Executive VP, H.D. Smith, Springfield, Ill.; H.D. Smith is one of the largest, privately held national full-service wholesale drug distributors. For more information, visit hdsmith.com. Paula Brown Stafford. Executive VP, Global Data Management, Quintiles Transnational Corp., Research Triangle Park, N.C.; Quintiles improves healthcare worldwide by providing quality professional expertise, market intelligence, and innovative partnering solutions to the pharmaceutical, biotechnology, and healthcare industries. For more information, visit quintiles.com. Jeff Steinberg. Pharmaceutical Leader, Business Risk Services, Ernst & Young LLP, New York; Ernst & Young helps organizations form the right alliances, access funding, and gain insight into the market and regulatory environment of today’s dynamic health-sciences market. For more information, visit ey.com. Marianne Stephen. President, HRA Research, Parsippany, N.J.; HRA is a market-research company that specializes in the pharmaceutical, biotechnology, and medical-device industries. For more information, visit hrarsearch.com. Jean Stephenne. President, GSK Biologicals, the vaccines division of GlaxoSmithKline, Rixensart, Belgium; GSK is one of the world’s leading vaccine manufacturers. For more information, visit gsk.com. Hugo Stephenson, M.D. President, Quintiles Strategic Research Services, Research Triangle Park, N.C.; Quintiles improves healthcare worldwide by providing quality professional expertise, market intelligence, and innovative partnering solutions to the pharmaceutical, biotechnology, and healthcare industries. For more information, visit quintiles.com. Sandy Stransky. VP, Sales, Impact Unlimited, Dayton, N.J.; Impact Unlimited provides a breadth of products and services that help companies optimize their investments in events, exhibits, and meetings. For more information, visit impactunlimited.com. Harry A. Sweeney. Chairman and CEO, Dorland Global Corp., Philadelphia; Dorland is a full-service healthcare communications and advertising agency. For more information, visit dorland.com. Roni Thaler. President and Cofounder, The Center for Information and Study on Clinical Research Participation (CISCRP), Boston; CISCRP is an independent, nonprofit organization founded in 2003 for the purpose of promoting understanding and awareness of the clinical-research process by providing educational information to the public, patients, medical, and research professionals by distribution of print, television, and radio public-service announcements; hosting of AWARE for All, Clinical Research Education and Awareness Days; and distribution of educational brochures. For more information, visit smartparticipant.org. Lafayette Thompson, Ph.D. President and CEO of iAdvantage Software Inc., Cary, N.C.; iAdvantage Software creates value for its clients by improving data communication, productivity, real-time business intelligence, and time to market through the use of electronic study management software for development and preclinical life-science studies for pharmaceutical and biotechnology companies. For more information, visit iadvantagesoftware.com. Richard Vanderveer, Ph.D. Group CEO, GfK U.S. Healthcare Companies, Blue Bell, Pa.; GfK is one of the largest providers of custom healthcare marketing-research services in the United States. For more information, visit gfkushc.com. Glenn Van Deusen. Corporate VP and General Manager, Medical Marketing Services, Parexel International, Waltham, Mass.; Parexel is a global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical marketing, consulting services, and technology products and services to the worldwide pharmaceutical, biotechnology, and medical-device industries. For more information, visit parexel.com. Michael Williams, Ph.D., D.Sc. VP, Worldwide Discovery Research, Cephalon Inc., Frazer, Pa.; Cephalon is an international biopharmaceutical company dedicated to the discovery, development, and marketing of innovative products to treat sleep and neurological disorders, cancer, and pain. For more information, visit cephalon.com. David Winigrad. President, The Hal Lewis Group Inc., Philadelphia; Hal Lewis is a full-service healthcare communications and advertising agency. For more information, visit hlg.com. David Wood. Chairman, Interbrand Wood Healthcare, New York; Interbrand Wood Healthcare is a full-service brand consultancy, dedicated to the healthcare industry that partners with pharmaceutical, biotech, medical-device, and animal-health companies to develop and manage some of their most valuable assets — their brands. For more information, visit interbrandwood.com. Susan Worthy. VP, Marketing, ClearStory Systems, Westborough, Mass.; ClearStory is an established provider of marketing content management (MCM) and enterprise content management (ECM) solutions for rich media. For more information, visit clearstorysystems.com. Kleanthis G. Xanthopoulos, Ph.D. President and CEO, Anadys Pharmaceuticals Inc., San Diego; Anadys is committed to advancing patient care by discovering, developing, and commercializing novel small-molecule medicines for the treatment of chronic viral infections and bacterial infections, hepatitis C virus (HCV), hepatitis B virus (HBV), and other serious infections. For more information, visit anadyspharma.com. Alex Zisson. Venture Partner, Thomas, McNerney & Partners, Stamford, Conn.; Thomas, McNerney & Partners is a healthcare private equity firm that invests in life-sciences and medical-technology companies at all stages of development. For more information, visit tm-partners.com.
